Tag: Screening

In an average-risk colorectal cancer screening population, a blood-based circulating tumor DNA test is feasible

Findings seen compared with telephone reminders for women overdue for screening in a safety-net setting

Only risk of any adenoma differed between the groups

Mammographically visible types more accurately localized by AI than nonvisible interval breast cancers

Noninvasive SS-ASOCT correctly diagnosed pediatric patients without early-onset childhood glaucoma

For women with extremely dense breasts negative for cancer at mammography, abbreviated MRI comparable to full multiparametric protocol

Fewer report using a screening tool at every well visit

Cost per additional cases of CRC, advanced neoplasia would still be manyfold higher if costs per test were lowered

Early, universal screening recommended; those not screened early should be screened at first opportunity

Approximate doubling of up-to-date status seen among Asian, Black, Hispanic, White patients, with corresponding decrease in CRC incidence, deaths